Coronavirus Research: Pfizer vaccine provokes immune response – Brinkwire

A Covid-19 vaccine made by the pharmaceutical company Pfizer has passed safety and effectiveness tests in early clinical trials, a study revealed today.
The jab, of which the UK Government has ordered 30million doses, is now another promising candidate for the vaccine considered so crucial to stopping the virus.
Early human trials of the injection, carried out by New York-based Pfizer and universities and hospitals in the US, have produced promising results.
People who received the vaccine pr…

Click here to view the original article.